Clinical trial
Post Authorization Safety Study of the Intramuscular Inactivated, Split Virion Pandemic A/H1N1 Influenza Vaccines in Children Aged Over 2 Months and in Adult Populations
NCT01032980 is registered in ClinicalTrials.gov with Sanofi Pasteur, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Authorization Safety Study of the Intramuscular Inactivated, Split Virion Pandemic A/H1N1 Influenza Vaccines in Children Aged Over 2 Months and in Adult Populations
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- July 31, 2011
- Enrollment
- 3,934 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
influenza, swine-origin a/h1n1 influenza virus